Oncolytics Biotech, Inc. Common Shares
$0.77
$0.00 (+0.00%)
$0.76Day Range$0.78
Key Statistics
Market Cap
$98.18M
Shares Outstanding
127.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 5, 2001
Round Lot
100
Locale
US
Trading Data
Day Open
$0.78
Day High
$0.78
Day Low
$0.76
Volume
314.0K
VWAP
$0.77
Prev Close
$0.77
Transactions
--
Acc. Volume
--
About Oncolytics Biotech, Inc. Common Shares
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
PHARMACEUTICAL PREPARATIONSSIC 283429 employeesSUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121(403) 670-7377IPO Oct 5, 2001US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001129928
- Composite FIGI
- BBG000DVS826
- Share Class FIGI
- BBG001SDGSF3
- Ticker Root
- ONCY
- SIC Code
- 2834
About Oncolytics Biotech, Inc. Common Shares (ONCY) Stock
Oncolytics Biotech, Inc. Common Shares (ONCY) closed the 2026-09-18 session at $0.77, up 0.00% versus the previous close (+0.00). The stock opened at $0.78 and traded between $0.76 and $0.78 during that session. Session trading volume was 314K shares. The volume-weighted average price (VWAP) is $0.77.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Oncolytics Biotech, Inc. Common Shares has a market capitalization of $98.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ONCY is listed on the XNAS exchange. The company employs approximately 29 people. Oncolytics Biotech, Inc. Common Shares is headquartered in SAN DIEGO, CA. The recorded listing date is 2001-10-05.
On this page you can find market ONCY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.